Isaac Scientific Publishing

Modern Organic Chemistry Research

Search of New Scaffolds against N-myristoyltransferase for Antifungal Activity

Download PDF (507.3 KB) PP. 1 - 9 Pub. Date: November 17, 2016

DOI: 10.22606/mocr.2016.11001

Author(s)

  • Sudha Vengurlekar*
    Sri Aurobindo Institute of Pharmacy, Indore, India
  • Reena Gupta
    Smriti College of Pharmaceutical Education, Indore, India

Abstract

N-myristoyltransferase (NMT) has been an emerging target for the design of novel antifungal agents with new mode of action. A series of furan and imidazole containing heterocyclic derivatives have been designed using rational drug designing approach as NMT inhibitors. Newly Designed compounds were synthesized, characterized and evaluated for their antifungal activity against NMT. Synthesized compounds were characterized by IR, NMR and Mass. In vitro antifungal assay indicated that these derivatives have shown moderate to good antifungal activity against five fungal strains. A possible antifungal target was identified (NMT) and furan derivatives showed more favorable affinity than the imidazole ligands.

Keywords

N-myristoyltranseferase, antifungal, antibacterial, molecular modeling, minimum inhibitory concentration.

References

[1] Kawasaki, K., Masubuch, M., Morikam, K., Tsujii S. and Ohtsuka T. (2003) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry Letters, 13, 87-91.

[2] Sogabe, S., Masubuchi, M., Niizuma, S. and Aoki Y. (2002) Crystal structures of Candida albicans N- myristoyltransferase with two distinct inhibitors. Chemistry and Biology, 9,1119-1128.

[3] Bhatnagar, R.S. and Futterer, K. (1998) Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs. Nature Structural Biology, 12, 1091-1097.

[4] Boutin, J.A. (1997) Myristoylation. Cellular Signalling, 1,15-39.

[5] Sogabe, S.M., Sakata, K., Takaai, A., Morikami, K., Shimma, N. and Winkler F. (2002) Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors. Chemical Biology, 9, 1119-1128.

[6] Demirayak, S. and Ucucu, U. (2002) Synthesis and antifungal activities of some aryl (benzofuran-2-yl) ketoximes. Il Farmaco, 57, 609-612.

[7] Rival, Y., Grassy, G., Taudou, A. and Ecalle, R. (1991) Antifungal activity in vitro of some imidazo [l,2- alpyrimidine derivatives. European Journal of Medicinal Chemistry, 26, 13-18.

[8] Silverstri, R. and Artico, M. (2004) Fluoxetine, a Novel Class of anti-Candida Agents. Journal of Medicinal Chemistry, 47, 3924-3926.

[9] Kawasaki, K., Masubuchi, M. and Ohtsuka T.(2003) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry Letters, 13, 87-91.

[10] Masubuchi, M. , Ebike, H., Liu, P. and Morikami, K. (2003)Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry, 11, 4463-4478.

[11] Wahab, K.M., Jahangir, A.M., Rashid, M.A. and Chowdhary, R. (2005) A new structural alternative in benzo[b]furans for antimicrobial activity. Bioorganic Medicinal Chemistry Letters, 13, 4796-4805.

[12] Karaburn, N.G. and Benkil, K.(2006) Synthesis and activities of some aryl [3-(imidazol-1-yl/triazol-1-yl methyle) benzofuran-2-yl]ketoximes. European Journal of Medicinal Chemistry, 41, 651-656.

[13] ZHU Jie, SHENG Chun-Quan, ZHANG Min, SONG Yun-Long, CHEN Jun, YU Jian-Xin, YAO Jian-Zhong, MIAO Zhen-Yuan and ZHANG Wan-Nian. (2006) 3D-QSAR Study of a Series of Novel Benzofuran NMT Inhibitors, Chemical Journal of Chinese Universities, 27, 287-29

[14] Kirimis, C., Koca, M., Servi, S. and Gur, S. (2009) Synthesis and antimicrobial activity of dinapthol [2,1- b]furan-2-yl-methanone and their oxime derivatives. Turkey Journal of Chemistry, 33, 374-380.

[15] Reddy, C.S. and Nagaraj, A. J.(2008) Synthesis and biological study of novel bis-chalcones, bis-thiazines and Bis-pyrimidines. Iranian Chemical Society, 5, 262-267.

[16] NCCLS, National Committee for Clinical Laboratory Standards. 2002, In Method M27-A2, 2nd ed.: Wayne, Ed.; Vol. 22, pp 1–29. In NCCLS, and method M-38A, 2nd ed.: Wayne Ed.; Vol. 22, pp 1–27.